Blind spots in health perception: the underestimated role of social connection for health outcomes.

Publication date: Feb 12, 2025

Robust evidence indicates that having few or poor-quality social connections is associated with poorer physical health outcomes and risk for earlier death (Snyder-Mackler N, Science 368, 2020; Vila J, Front Psychol 12:717164, 2021). This study sought to determine whether recent attention on social connection and loneliness brought on by the COVID-19 pandemic may influence risk perception and whether these perceptions were heightened among those who are lonely. Two waves of online survey data were collected. The first included data from 1,486 English-speaking respondents in the US, UK, and Australia, and a second sample of 999 nationally representative US adults, with a final sample of 2392 respondents from the US and UK. Perceptions of risk have remained consistent, underestimating the influence of social factors on health outcomes and longevity, even among respondents who reported moderate-to-severe levels of loneliness. Despite heightened awareness and discourse during the COVID-19 pandemic, public perception in the US and UK continues to significantly underestimate the impact of social factors on physical health and mortality. This underestimation persists regardless of individual loneliness levels, underscoring the need for enhanced public education and policy efforts to recognize social connection as a crucial determinant of health outcomes.

Open Access PDF

Concepts Keywords
Australia Adolescent
Covid Adult
Deathsnyder Aged
Loneliness Australia
COVID-19
Covid-19
Female
Health
Humans
Loneliness
Loneliness
Male
Middle Aged
Mortality
Social Distancing
Social Integration
Social Support
Surveys and Questionnaires
United Kingdom
United States
Young Adult

Semantics

Type Source Name
disease IDO role
disease IDO quality
disease MESH death
disease MESH loneliness
disease MESH COVID-19 pandemic
pathway REACTOME Reproduction
disease MESH Lifestyle factors
disease MESH physical inactivity
disease MESH inadequate sleep
drug DRUGBANK Methionine
disease MESH morbidity
disease MESH stroke
disease MESH dementia
disease IDO susceptibility
drug DRUGBANK Coenzyme M
drug DRUGBANK Ethanol
disease MESH obesity
drug DRUGBANK Medical air
disease MESH Emergency
drug DRUGBANK Polyethylene glycol
drug DRUGBANK Stavudine
disease IDO country
drug DRUGBANK Ademetionine
disease IDO replication
disease MESH chronic disease
drug DRUGBANK Trestolone
disease MESH functional status
disease MESH depression
disease MESH anxiety
disease MESH Cognitive Impairment
disease MESH Underweight
disease MESH diabetes mellitus
pathway KEGG Coronavirus disease
disease MESH Heart Disease
disease MESH overweight
disease MESH Coronary Heart Disease
drug DRUGBANK Nicotine
drug DRUGBANK Guanosine
disease MESH Weight Gain
disease MESH Cardiovascular Risk
disease MESH influenza
disease MESH respiratory diseases
drug DRUGBANK Methyl isocyanate
drug DRUGBANK Sodium Tetradecyl Sulfate
drug DRUGBANK Aspartame

Original Article

(Visited 1 times, 1 visits today)